Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins

Citation
A. Achiron et al., Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins, J AUTOIMMUN, 15(3), 2000, pp. 323-330
Citations number
30
Categorie Soggetti
Immunology
Journal title
JOURNAL OF AUTOIMMUNITY
ISSN journal
08968411 → ACNP
Volume
15
Issue
3
Year of publication
2000
Pages
323 - 330
Database
ISI
SICI code
0896-8411(200011)15:3<323:SOEAEB>2.0.ZU;2-L
Abstract
Experimental autoimmune encephalomyelitis (EAB) was induced in Lewis rats e ither by active immunization with myelin basic protein (MBP) or by adoptive transfer using anti-MBP specific CD4(+) T cells. Treatment with human poly clonal immunoglobulins (IgG) effectively suppressed active EAE. Time-depend ent experiments demonstrated that the effect of IgG was manifested only whe n treatment was given immediately after immunization; administration from d ay 7 after disease induction did not suppress the disease. in the adoptive transfer model of EAE, IgG had no effect in vivo. However, pretreatment in vitro of the antigen-specific T-cells with IgG inhibited their ability to m ediate adoptive EAE, as it did in active EAE. Similarly, in vitro IgG pretr eatment of the antigen-specific T-cells suppressed the proliferative respon se to MBP. Fluorescent Activated Cell Sorter (FACS) analysis demonstrated t he binding of IgG to activated T-cell lines that was inhibited by soluble F e molecules. The differential effects of IgG on active EAE and on the adopt ive transfer of EAE suggest that IgG in vivo can suppress disease by acting during the early phase of the immune response which involves naive T cells . The inhibition of T-cell proliferation and adoptive transfer of EAE by in cubation of T cells in vitro appears to require higher concentrations of Ig G than those obtained in vivo. (C) 2000 Academic Press.